However, few clinically detectable solid tumors simply vanish, despite the presence of tumor-infiltrating lymphocytes (TIL). The potentially lethal TIL are instead held at bay by immunosuppressive ...

Let's find out whether that's the case, or if it's best to avoid Iovance. Iovance Biotherapeutics is an oncology specialist.

Approximately 100,000 people in the U.S. will be diagnosed with melanoma this year, according to the American Cancer Society.

Researchers investigate the functionality and tumor-specificity of immune cells, including tumor-infiltrating lymphocytes (TILs), to uncover the immunotherapy resistance mechanisms in human ...

Deficiency or pharmacological inhibition of O-glcNac transferase (OGT) enhances tumor immunity in colorectal cancer models.

Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering ...

By Susha Cheriyedath, M.Sc. Researchers discover a novel protein therapy that recharges exhausted T cells, unleashing their ...

Detailed price information for Summit Therapeu ADR (SMMT-Q) from The Globe and Mail including charting and trades.

The United States market has been flat over the last week, but it has seen a significant rise of 34% over the past 12 months, with earnings forecasted to grow by 15% annually. In this context, ...

The approval of tumor-infiltrating lymphocytes for melanoma was a "watershed event. That opens the gates." Luke is collaborating with Immatics in the development of a T-cell receptor-transduced T-cell ...

The utility of an in vitro cell culture system for studies of molecular mechanisms underlying the initial induction and subsequent propagation of environmentally induced epimutations is demonstrated.